In this week’s edition of InnovationRx, we look at the Khosla Ventures-Cleveland Clinic partnership, Town Hall Ventures’ $440 million haul, the CDC’s “Friday night massacre,” Boehringer’s new pulmonary fibrosis drug, and more. To get it in your inbox, subscribe here . At the London launch event (from left to right) Dr. Geoff Vince and Dr. Serpil Ezerum of Cleveland Clinic and Alex Morgan and Hal Paz of Khosla Ventures. Cleveland Clinic

N ew technologies are transforming the way that hospitals operate . To try and gain an edge, Khosla Ventures and Cleveland Clinic signed a deal in which the health system will test new technologies that span AI, digital health and next-generation therapeutics from the VC firm’s portfolio companies—and the two will explore opportunities to incuba

See Full Page